Abstract Submission

Go to Submission form »

All abstracts must be submitted electronically and will be subjected to review by the scientific committee before being accepted.

Abstracts must be scientific in nature and address an appropriate topic of discussion without inclusion of commercial message or inappropriate references to specific products, services, or commercial concerns. All abstracts must be of a maximum 250 words in length and submitted in English. Tables, graphs, and structural formulae may not be included, although simple mathematical formulae are acceptable.

All abstracts must be submitted within the Clinical, Physics, or Biology categories listed below.


The deadline for acceptance is March 15, 2011 and abstracts received after this date will not be accepted. Once the abstract has been received, a confirmation message will be sent to the corresponding author within 7 calendar days. If no confirmation is received by that time then the responsible author should contact the ESHO 2011 Secretariat.

Abstract categories:


  1. Randomized trials
  2. Uterine cervix cancer
  3. Abdominal metastases and peritoneal carcinomatosis
  4. Prostate cancer
  5. Sarcoma and melanoma
  6. Locally advanced head and neck cancer
  7. Breast cancer
  8. Miscellanea


  1. Treatment planning
  2. HIFU
  3. Thermal ablation
  4. Thermometry
  5. Miscellanea


  1. Radiotherapy and hyperthermia
  2. Chemotherapy and hyperthermia
  3. Pathophysiological effects
  4. DNA-repair
  5. Immune effects
  6. Nano particles
  7. Miscellanea